CSPC Pharmaceutical Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 2, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	104,612	55,169	86,022	97,707	100,932	94,800
Market Cap Growth	108.11%	-35.87%	-11.96%	-3.19%	6.47%	-18.19%
Enterprise Value	96,312	45,415	74,600	84,557	88,212	87,594
Last Close Price	9.15	4.65	6.73	7.30	7.35	6.77
PE Ratio	23.63	11.98	13.30	14.19	14.67	15.47
Forward PE	17.84	9.76	12.05	13.86	15.70	15.49
PS Ratio	3.65	1.79	2.48	2.79	2.95	3.20
PB Ratio	2.75	1.53	2.23	2.73	3.07	3.46
P/TBV Ratio	3.15	1.76	2.53	3.08	3.24	3.68
P/FCF Ratio	-	20.58	30.56	15.99	25.49	14.83
P/OCF Ratio	-	11.43	18.68	11.33	17.73	11.84
PEG Ratio	2.00	1.10	1.30	0.76	1.25	1.03
EV/Sales Ratio	3.36	1.47	2.15	2.42	2.58	2.96
EV/EBITDA Ratio	15.91	6.62	8.53	9.83	10.31	11.98
EV/EBIT Ratio	21.16	7.95	9.65	11.07	11.50	13.48
EV/FCF Ratio	-	16.94	26.50	13.83	22.27	13.70
Debt / Equity Ratio	0.01	0.02	0.02	0.02	0.00	0.01
Debt / EBITDA Ratio	0.09	0.08	0.09	0.08	0.01	0.05
Debt / FCF Ratio	-	0.20	0.28	0.11	0.03	0.06
Asset Turnover	-	0.64	0.71	0.81	0.86	0.89
Inventory Turnover	-	2.78	3.26	3.45	3.10	2.85
Quick Ratio	-	1.95	2.32	2.39	2.47	2.22
Current Ratio	-	2.27	2.63	2.67	2.81	2.53
Return on Equity (ROE)	-	12.60%	18.22%	21.32%	22.79%	24.54%
Return on Assets (ROA)	-	7.40%	9.96%	11.04%	12.05%	12.13%
Return on Invested Capital (ROIC)	13.02%	17.69%	29.11%	33.40%	34.94%	31.93%
Return on Capital Employed (ROCE)	-	15.40%	19.40%	20.60%	22.70%	23.00%
Earnings Yield	4.24%	8.35%	7.52%	7.05%	6.82%	6.46%
FCF Yield	-	4.86%	3.27%	6.26%	3.92%	6.74%
Dividend Yield	2.71%	5.59%	4.22%	2.96%	2.54%	1.88%
Payout Ratio	-	74.72%	46.42%	34.42%	30.16%	29.61%
Buyback Yield / Dilution	2.93%	1.14%	0.38%	0.29%	0.01%	0.00%
Total Shareholder Return	5.64%	6.73%	4.60%	3.25%	2.55%	1.88%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.